A Randomized, Crossover, Open-label Phase 1 Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)

Trial Profile

A Randomized, Crossover, Open-label Phase 1 Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2015

At a glance

  • Drugs Glycerol phenylbutyrate (Primary)
  • Indications Hepatic encephalopathy; Hyperammonaemia
  • Focus Adverse reactions
  • Sponsors Horizon Pharma; Hyperion Therapeutics
  • Most Recent Events

    • 27 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top